Late effects of chemotherapeutic agents on renal function in childhood cancer survivors: a review of the literature
Author:
- 23 June 2016
- journal article
- review article
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 186 (1) , 49-55
Abstract
Survival outcomes for childhood cancers have significantly improved. As more children are now surviving into adulthood, knowledge of the long-term effects of childhood cancer treatments has become the focus of research. To determine what is known about the incidence of renal function impairment in childhood cancer survivors and to determine what is known about risk factors for developing renal function impairment following childhood cancer treatment. A comprehensive literature search was preformed to identify studies that investigated renal dysfunction in patients who were diagnosed with childhood cancer and treated with potentially nephrotoxic chemotherapeutic agents. Potentially nephrotoxic chemotherapeutic agents identified in the selection criteria include ifosfamide, cisplatin, carboplatin and methotrexate. 15 papers met the inclusion criteria. Renal function impairment was reported in 15 of 15 studies included in this literature review. The incidence of ifosfamide induced nephrotoxicity varied from 1 to 50 %. This variation may be due to the heterogeneity of reported outcome measurements. Treatment with cisplatin and carboplatin was associated with hypomagnesemia. The prevalence of hypomagnesemia varied from 7 to 29 %. This variation may be due to diversity of treatment protocols. The incidence of renal dysfunction following treatment with methotrexate was reported as 1.8 % and completely reversible. As more childhood cancer survivors are reaching adulthood, a new niche of cancer research has emerged. Researchers are now investigating the late effects due to cytotoxic treatments. Renal function impairment is a potential late effect of treatment with nephrotoxic chemotherapeutic agents including ifosfamide, cisplatin, carboplatin and methotrexate.Keywords
This publication has 17 references indexed in Scilit:
- Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factorsEuropean Journal of Cancer, 2009
- Renal late effects in patients treated for cancer in childhood: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2008
- Long‐term follow‐up of renal function after high‐dose methotrexate treatment in childrenPediatric Blood & Cancer, 2008
- Late effects surveillance system for sarcoma patientsPediatric Blood & Cancer, 2003
- TrueBritish Journal of Cancer, 2000
- Dose-related nephrotoxicity of carboplatin in childrenBritish Journal of Cancer, 1999
- Cisplatin therapy in childhood: renal follow up 3 years or more after treatmentNephrology Dialysis Transplantation, 1999
- Risk Factors for Long‐Term Outcome of Ifosfamide‐Induced Nephrotoxicity in ChildrenThe Journal of Clinical Pharmacology, 1999
- Cisplatin and hypomagnesemiaCancer Treatment Reviews, 1999
- Partial reversibility of cisplatin nephrotoxicity in childrenThe Journal of Pediatrics, 1991